Fuse Oncology and AMP launch trial of FuseRx workflow platform

Fuse Oncology has entered into a strategic collaboration with AMP to initiate a proof of concept of its FuseRx clinical workflow platform. The evaluation will take place at AMP’s Center of Advanced Radiation Excellence in Syracuse, New York, US. The FuseRx platform aims to consolidate clinical and administrative functions from consultation through to treatment. Credit: Andrei_R / Shutterstock.com. Fuse Oncology has entered a strategic collaboration with Associated Medical Professionals of New York (AMP) to initiate a proof of concept of its FuseRx clinical workflow platform. Operating as an affiliate of US Urology Partners, a General Atlantic company, AMP will conduct…

Source: Medical Device Network